{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:21:09Z","timestamp":1791249669948,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS125255"],"award-info":[{"award-number":["R01 NS125255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.gim.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:42:03Z","timestamp":1657586523000},"page":"1993-2003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Genetic counseling for prion disease: Updates and best practices"],"prefix":"10.1016","volume":"24","author":[{"given":"Jill S.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3824-2702","authenticated-orcid":false,"given":"Sonia M.","family":"Vallabh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1212\/WNL.0000000000008680","article-title":"Prion disease incidence in the United States: 2003-2015","volume":"94","author":"Maddox","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.gim.2022.06.003_bib2","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/jnnp-2012-304820","article-title":"Intensity of human prion disease surveillance predicts observed disease incidence","volume":"84","author":"Klug","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.gim.2022.06.003_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-genet-120213-092352","article-title":"Genetic factors in mammalian prion diseases","volume":"53","author":"Mead","year":"2019","journal-title":"Annu Rev Genet"},{"issue":"23","key":"10.1016\/j.gim.2022.06.003_bib4","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 10","key":"10.1016\/j.gim.2022.06.003_bib5","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","article-title":"Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies","volume":"127","author":"Pocchiari","year":"2004","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-132465","article-title":"Initial diagnoses of patients ultimately diagnosed with prion disease","volume":"42","author":"Appleby","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/v13050789","article-title":"Clinical use of improved diagnostic testing for detection of prion disease","volume":"13","author":"Figgie","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.gim.2022.06.003_bib8","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of prion diseases by\u00a0RT-QuIC results in improved surveillance","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.gim.2022.06.003_bib9","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1007\/s12035-016-9918-y","article-title":"Hereditary human prion diseases: an update","volume":"54","author":"Schmitz","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"322","key":"10.1016\/j.gim.2022.06.003_bib10","doi-asserted-by":"crossref","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib12","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age of onset in genetic prion disease and the design of preventive clinical trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1054\/jocn.2001.0919","article-title":"Gerstmann-Str\u00e4ussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies","volume":"8","author":"Collins","year":"2001","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.gim.2022.06.003_bib14","series-title":"Handbook of Clinical Neurology [Internet]","first-page":"441","article-title":"Gala II, Geschwind MD. Prion disease","author":"Takada","year":"2018"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.25579","article-title":"Clinical variability in P102L Gerstmann-Str\u00e4ussler-Scheinker syndrome","volume":"86","author":"Tesar","year":"2019","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1212\/WNL.51.5.1398","article-title":"Phenotypic variability in fatal familial insomnia (D178N-129M) genotype","volume":"51","author":"Zerr","year":"1998","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.gim.2022.06.003_bib17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/jnnp.2004.056606","article-title":"Phenotypic variability in familial prion diseases due to the D178N mutation","volume":"76","author":"Zarranz","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/19336896.2015.1054601","article-title":"Familial fatal insomnia with atypical clinical features in a patient with D178N mutation and homozygosity for Met at codon 129 of the prion protein gene","volume":"9","author":"Sun","year":"2015","journal-title":"Prion"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/WAD.0b013e3181ae3a76","article-title":"A\u00a0case of dementia with PRNP D178Ncis-129M and no insomnia","volume":"23","author":"Guerreiro","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.68.3.388","article-title":"Familial Creutzfeldt-Jakob disease with D178N-129M mutation of PRNP presenting as cerebellar ataxia without insomnia","volume":"68","author":"Taniwaki","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"18","key":"10.1016\/j.gim.2022.06.003_bib21","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2169\/internalmedicine.0573-17","article-title":"Fatal familial insomnia initially developing parkinsonism mimicking dementia with Lewy bodies","volume":"57","author":"Fukuoka","year":"2018","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.49.2.552","article-title":"The D178N (cis-129M) \u201cfatal familial insomnia\u201d mutation associated with diverse clinicopathologic phenotypes in an Australian kindred","volume":"49","author":"McLean","year":"1997","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jnnp.2008.149922","article-title":"Prion mutation D178N with highly variable disease onset and phenotype","volume":"80","author":"Synofzik","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.gim.2022.06.003_bib24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnen\/nlx068","article-title":"Different complicated brain pathologies in monozygotic twins with Gerstmann-Str\u00e4ussler-Scheinker disease","volume":"76","author":"Honda","year":"2017","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"9137","key":"10.1016\/j.gim.2022.06.003_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(05)60749-0","article-title":"Discordant Gerstmann-Str\u00e4ussler-Scheinker disease in monozygotic twins","volume":"352","author":"Hamasaki","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2990.2009.01012.x","article-title":"Seven-year discordance in age at onset in monozygotic twins with inherited prion disease (P102L)","volume":"35","author":"Webb","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.32505","article-title":"Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature","volume":"174","author":"Takada","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneurol.2014.263","article-title":"A\u00a0new prion disease: relationship with central and peripheral amyloidoses","volume":"11","author":"Mead","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.gim.2022.06.003_bib29","doi-asserted-by":"crossref","first-page":"265.e1","DOI":"10.1016\/j.neurobiolaging.2018.05.011","article-title":"Evaluating the causality of novel sequence variants in the prion protein gene by example","volume":"71","author":"Mok","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajhg.2014.09.003","article-title":"Ascertainment bias causes false signal of anticipation in genetic prion disease","volume":"95","author":"Minikel","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gim.2022.06.003_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2188\/jea.JE20100085","article-title":"Duration of prion disease is longer in Japan than in other countries","volume":"21","author":"Nagoshi K","year":"2011","journal-title":"J Epidemiol"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.49.1.133","article-title":"Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family","volume":"49","author":"Capellari","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.gim.2022.06.003_bib67","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1038\/s41598-022-12130-7","article-title":"Prion protein gene mutation detection using long-read nanopore sequencing","volume":"12","author":"Kroll F","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/bmb\/66.1.255","article-title":"Acquired prion disease: iatrogenic CJD, variant CJD, kuru","volume":"66","author":"Will","year":"2003","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12916-020-01608-8","article-title":"Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease","volume":"18","author":"Vallabh","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/19336896.2021.1933872","article-title":"Creutzfeldt-Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues","volume":"15","author":"Luk","year":"2021","journal-title":"Prion"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/vox.12371","article-title":"Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study","volume":"110","author":"Urwin","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.gim.2022.06.003_bib36","series-title":"WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease","year":"2003"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jgc4.1377","article-title":"A\u00a0family systems approach to genetic counseling: development of narrative interventions","volume":"30","author":"MacLeod","year":"2021","journal-title":"J\u00a0Genet Couns"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/302374","article-title":"A\u00a0worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease","volume":"64","author":"Almqvist","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1034\/j.1399-0004.2003.00157.x","article-title":"Canadian Collaborative Study of Predictive Testing. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington\u2019s disease","volume":"64","author":"Almqvist","year":"2003","journal-title":"Clin Genet"},{"issue":"10","key":"10.1016\/j.gim.2022.06.003_bib40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5200532","article-title":"Psychological consequences of predictive genetic testing: a systematic review","volume":"8","author":"Broadstock","year":"2000","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ejhg.2008.146","article-title":"Long-term outcome of presymptomatic testing in Huntington disease","volume":"17","author":"Gargiulo","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.gim.2022.06.003_bib42","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s10897-015-9822-z","article-title":"Do attachment style and emotion regulation strategies indicate distress in predictive testing?","volume":"24","author":"van der Meer","year":"2015","journal-title":"J\u00a0Genet Couns"},{"issue":"10","key":"10.1016\/j.gim.2022.06.003_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejmg.2018.03.010","article-title":"Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases","volume":"61","author":"L\u00eado","year":"2018","journal-title":"Eur J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0809578","article-title":"Disclosure of APOE genotype for risk of Alzheimer\u2019s disease","volume":"361","author":"Green","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gim.2022.06.003_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pneurobio.2013.08.003","article-title":"A\u00a0review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases","volume":"110","author":"Paulsen","year":"2013","journal-title":"Prog Neurobiol"},{"issue":"6","key":"10.1016\/j.gim.2022.06.003_bib46","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s10897-018-0257-1","article-title":"What to do with a second chance in life? Long-term experiences of non-carriers of Huntington\u2019s disease","volume":"27","author":"Winnberg","year":"2018","journal-title":"J\u00a0Genet Couns"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.psc.2015.01.008","article-title":"Genetic testing and counseling in the diagnosis and management of young-onset dementias","volume":"38","author":"Goldman","year":"2015","journal-title":"Psychiatr Clin North Am"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","article-title":"Recommendations for the predictive genetic test in Huntington\u2019s disease","volume":"83","author":"MacLeod","year":"2013","journal-title":"Clin Genet"},{"issue":"7-8","key":"10.1016\/j.gim.2022.06.003_bib49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/21678421.2017.1332079","article-title":"Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations","volume":"18","author":"Crook","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/153331750502000408","article-title":"Emotional reactions to predictive testing in Alzheimer\u2019s disease and other inherited dementias","volume":"20","author":"Molinuevo","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/GIM.0b013e318204d004","article-title":"Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis","volume":"13","author":"Fanos","year":"2011","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10897-014-9755-y","article-title":"The psychological impact of predictive genetic testing for Huntington\u2019s disease: a systematic review of the literature","volume":"24","author":"Crozier","year":"2015","journal-title":"J\u00a0Genet Couns"},{"issue":"12","key":"10.1016\/j.gim.2022.06.003_bib53","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0277-9536(99)00244-0","article-title":"Psychological impact of predicting individuals\u2019 risks of illness: a systematic review","volume":"49","author":"Shaw","year":"1999","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.gim.2022.06.003_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/GIM.0b013e31815f524f","article-title":"A\u00a0systematic review of perceived risks, psychological and behavioral impacts of genetic testing","volume":"10","author":"Heshka","year":"2008","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/gtmb.2012.0288","article-title":"Perception, experience, and response to genetic discrimination in Huntington\u2019s disease: the Australian results of the International RESPOND-HD study","volume":"17","author":"Goh","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib56","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymgme.2010.12.001","article-title":"Experience over fifteen years with a protocol for predictive testing for Huntington disease","volume":"102","author":"Dufrasne","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"1-3","key":"10.1016\/j.gim.2022.06.003_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pec.2006.03.002","article-title":"Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk","volume":"64","author":"Gooding","year":"2006","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.gim.2022.06.003_bib58","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fgene.2019.00895","article-title":"Genetic testing in prion disease: psychological consequences of the decisions to know or not to know","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.gim.2022.06.003_bib59","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ejhg.2014.42","article-title":"Predictive testing for inherited prion disease: report of 22 years experience","volume":"22","author":"Owen","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.gim.2022.06.003_bib60","doi-asserted-by":"crossref","first-page":"a036525","DOI":"10.1101\/cshperspect.a036525","article-title":"Predictive genetic counseling for neurodegenerative diseases: past, present, and future","volume":"10","author":"Goldman","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.gim.2022.06.003_bib61","first-page":"676","article-title":"Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review","volume":"269","author":"Crook","year":"2022","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.gim.2022.06.003_bib62","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ejhg.2013.143","article-title":"Experiences of predictive testing in young people at risk of Huntington\u2019s disease, familial cardiomyopathy or hereditary breast and ovarian cancer","volume":"22","author":"MacLeod","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamaneurol.2013.5884","article-title":"Preimplantation genetic diagnosis (PGD) for genetic prion disorder due to F198S mutation in the PRNP gene","volume":"71","author":"Uflacker","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.gim.2022.06.003_bib64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(19)30403-X","article-title":"Towards a treatment for genetic prion disease: trials and biomarkers","volume":"19","author":"Vallabh","year":"2020","journal-title":"Lancet Neurol"},{"issue":"19","key":"10.1016\/j.gim.2022.06.003_bib65","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","article-title":"Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints","volume":"48","author":"Minikel","year":"2020","journal-title":"Nucleic Acids Res"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022008127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022008127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:52:45Z","timestamp":1761097965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360022008127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1098360022008127"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2022.06.003","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic counseling for prion disease: Updates and best practices","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}]}}